Impact of symptom focusing and somatosensory amplification on persistent physical symptoms: A three-year follow-up study
- PMID: 32473411
- PMCID: PMC7614434
- DOI: 10.1016/j.jpsychores.2020.110131
Impact of symptom focusing and somatosensory amplification on persistent physical symptoms: A three-year follow-up study
Abstract
Objective: The somatosensory amplification theory considers symptom focusing and somatosensory amplification as important perpetuating factors of persistent physical symptoms. We investigated whether symptom focusing and somatosensory amplification were associated with symptom severity and mental and physical functioning over a three-year period in patients with persistent physical symptoms (PPS).
Methods: Baseline, 6-, 12-, 24- and 36-months follow-up data from the PROSPECTS study, a prospective cohort consisting of 325 patients with PPS, were used. We applied longitudinal mixed model analyses to investigate if symptom focusing (CBRQ Symptom Focusing Subscale) and somatosensory amplification (Somatosensory Amplification Scale) at baseline were associated with symptom severity (PHQ-15), mental and physical functioning (RAND-36 MCS and PCS) over three years, using all measurements.
Results: Symptom focusing was associated with increased symptom severity and lower mental and physical functioning over time. Somatosensory amplification at baseline was associated with increased symptom severity and lower mental and physical functioning over time. Effect sizes were small. Associations with baseline symptom focusing decreased over time, associations with baseline somatosensory amplification were more stable. There was no interaction effect of both constructs, but they partly overlapped.
Conclusion: This is the first study to show that over an extended period, symptom focusing and somatosensory amplification are associated with symptom severity and lower mental and physical functioning in patients with PPS. These results support the impact of both symptom focusing and somatosensory amplification on the perpetuation of symptoms and lowered mental and physical functioning in individuals with PPS.
Keywords: Medically unexplained symptoms; Perpetuating factors; Persistent physical symptoms; Somatosensory amplification; Symptom focusing.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf and declare that apart from the institutional grants mentioned above, there are no other potential competing interests to report.
Similar articles
-
Predicting the course of persistent physical symptoms: Development and internal validation of prediction models for symptom severity and functional status during 2 years of follow-up.J Psychosom Res. 2018 May;108:1-13. doi: 10.1016/j.jpsychores.2018.02.009. Epub 2018 Feb 21. J Psychosom Res. 2018. PMID: 29602318
-
Exploring maladaptive cognitions and behaviors as perpetuating factors in patients with persistent somatic symptoms: a longitudinal study.J Psychosom Res. 2023 Jul;170:111343. doi: 10.1016/j.jpsychores.2023.111343. Epub 2023 May 2. J Psychosom Res. 2023. PMID: 37201294
-
Five-year trajectories of symptom severity, physical and mental functioning in patients with persistent somatic symptoms: the PROSPECTS cohort study.BMJ Open. 2025 Jan 8;15(1):e083276. doi: 10.1136/bmjopen-2023-083276. BMJ Open. 2025. PMID: 39779277 Free PMC article.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Recent developments on psychological factors in medically unexplained symptoms and somatoform disorders.Front Public Health. 2022 Nov 4;10:1033203. doi: 10.3389/fpubh.2022.1033203. eCollection 2022. Front Public Health. 2022. PMID: 36408051 Free PMC article.
-
Measurement Properties of the Patient Health Questionnaire-15 and Somatic Symptom Scale-8: A Systematic Review and Meta-Analysis.JAMA Netw Open. 2024 Nov 4;7(11):e2446603. doi: 10.1001/jamanetworkopen.2024.46603. JAMA Netw Open. 2024. PMID: 39565620 Free PMC article.
-
Psychological factors and obesity, not thyroid biomarkers, predict thyroid-dependent quality of life in treated hypothyroidism: a cross-sectional study.BMC Endocr Disord. 2025 May 26;25(1):136. doi: 10.1186/s12902-025-01962-9. BMC Endocr Disord. 2025. PMID: 40420021 Free PMC article.
-
Validation and Factor Structure Analysis of the Polish Version of the Somatosensory Amplification Scale (SSAS-PL) in Clinical and Non-Clinical Samples.J Clin Med. 2025 Jul 8;14(14):4846. doi: 10.3390/jcm14144846. J Clin Med. 2025. PMID: 40725537 Free PMC article.
-
Psychological factors associated with Long COVID: a systematic review and meta-analysis.EClinicalMedicine. 2024 Jul 26;74:102756. doi: 10.1016/j.eclinm.2024.102756. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39764180 Free PMC article.
References
-
- Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62(8):903–10. - PubMed
-
- Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W, Konig HH. Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom. 2012;81(5):265–75. - PubMed
-
- Barsky AJ, Wyshak G. Hypochondriasis and somatosensory amplification. Br J Psychiatry. 1990;157:404–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources